are glp- 1 makers being sued ⚠️ CHICAGO CONSUMER ALERT: The FDA has confirmed that counterfeit versions of popular GLP-1 weight-loss drugs—including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are circulating in the U.S., and the Chicago area is Mounjaro Lawsuit - July 2026
Description
It plays a key role in regulating blood sugar levels by stimulating insulin secretion, inhibiting glucagon release, slowing gastric emptying and promoting a feeling of fullness

Medications like Topiramate and Semaglutide have shown noticeable effectiveness in reducing appetite and changing food perceptions

This adjustment period can temporarily alter bowel movements, causing looser stools or diarrhea as your system recalibrates
abrupt discontinuation Ongoing behavioral support Underlying metabolic factors Psychological factors Minimizing Weight Regain : Maintain strong nutrition and physical activity habits developed during treatment Consider gradual dose reduction rather than abrupt stopping Continue working with healthcare provider and coach during transition Monitor weight closely
